openPR Logo
Press release

Ribose-Nucleic Acid (RNA)-Based Therapeutics Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts

05-30-2025 08:15 AM CET | Health & Medicine

Press release from: The Business Research Company

Ribose-Nucleic Acid (RNA)-Based Therapeutics

Ribose-Nucleic Acid (RNA)-Based Therapeutics

The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Size During the Forecast Period?
The ribose-nucleic acid (RNA)-based therapeutics market has seen robust growth. It will expand from $15.79 billion in 2024 to $17.26 billion in 2025, with a CAGR of 9.3%. The increase is due to rising investments, breakthroughs like RNA interference (RNAi), successful clinical use of antisense oligonucleotides (ASOs), regulatory advancements, and strategic collaborations.

The ribose-nucleic acid (RNA)-based therapeutics market is projected to experience strong growth, reaching $24.26 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth is attributed to the expansion of indications, rising market demand, regulatory support, integration of AI and machine learning, and emerging applications in rare diseases. Key trends include advanced delivery systems, multi-target RNA therapeutics, customized RNA therapies, regulatory advancements, and commercialization.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18454

What Are the High-Growth Segments in the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
The ribose-nucleic acid (RNA)-based therapeutics market covered in this report is segmented -

1) By Type: RNA Interference (RNAi), RNA Antisense
2) By Technology: Enabling Technology, Enabled Technology
3) By Therapeutic Area: Oncology, Genetic Disorder, Ophthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Other Therapeutic Areas
4) By End User: Research Institutes, Hospitals And Clinics

Subsegments:
1) By RNA Interference (RNAi): Small Interfering RNA (siRNA), MicroRNA (miRNA)
2) By RNA Antisense: Antisense Oligonucleotides (ASOs), Antisense RNA

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18454&type=smp

What Key Drivers Are Expected to Influence Future Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Growth?
The increasing occurrence of cancer is expected to support growth in the ribose-nucleic acid (RNA)-based therapeutics market. Cancer involves the uncontrolled division of abnormal cells and is rising due to aging, lifestyle factors, and improved diagnostics. RNA-based therapies target genetic mechanisms at the molecular level for effective treatment. According to the Australian Institute of Health and Welfare in August 2023, around 151,000 cancer cases were diagnosed in 2021, with projections rising to 185,000 by 2030. Thus, cancer prevalence is propelling this therapeutics market.

Which Companies Hold the Largest Share Across Different Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Segments?
Major companies operating in the ribose-nucleic acid (RNA)-based therapeutics market are F. Hoffmann-La Roche AG, Eli Lilly and Company, Novo Nordisk A/S, Regeneron Pharmaceuticals, Biogen Inc., Houston Methodist Hospital, BioNTech, University of Oxford, Alnylam Pharmaceuticals, Sarepta Therapeutics, Flagship Pioneering, Ionis Pharmaceuticals, Akcea Therapeutics Inc, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Wave Life Sciences, Pharmaceutical Technology, Quark Pharmaceuticals, Tekmira Pharmaceuticals, ReCode Therapeutics, Arbutus Biopharma Corporation, Benitec Biopharma Inc., Olix Pharmaceuticals, Alltrna Inc., Orbital Therapeutics

What Are the Major Trends Shaping the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
Leading companies in the RNA-based therapeutics market are developing new solutions such as mRNA-based booster vaccines to improve immunization effectiveness, address emerging viral variants, and enhance the longevity of vaccine-induced immunity. For example, in June 2023, India's Gennova Biopharmaceuticals Ltd. launched GEMCOVAC-OM, the first mRNA booster vaccine in India designed to target the Omicron variant of COVID-19. This booster aims to enhance immunity and offer better protection against the Omicron variant.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/ribose-nucleic-acid-rna-based-therapeutics-global-market-report

What Are the Emerging Geographies for The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Growth?
North America was the largest region in the ribose-nucleic acid (RNA)-based therapeutics market in 2024. The regions covered in the ribose-nucleic acid (RNA)-based therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
2. What is the CAGR expected in the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
3. What Are the Key Innovations Transforming the Ribose-Nucleic Acid (RNA)-Based Therapeutics Industry?
4. Which Region Is Leading the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ribose-Nucleic Acid (RNA)-Based Therapeutics Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts here

News-ID: 4043902 • Views:

More Releases from The Business Research Company

Emerging Markets And Increasing Disposable Income Fueling Diamond Market Growth: Powering Innovation and Expansion in the Diamond Market by 2025
Emerging Markets And Increasing Disposable Income Fueling Diamond Market Growth: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Diamond Market Through 2025? In the past few years, there has been a stable expansion in the diamond market size. The prediction is it will increase from $1.33 billion in 2024 to $1.39 billion in 2025, boasting a compound annual growth rate
2025-2034 Nonmetallic Minerals Mining Support Activities Market Outlook: Key Drivers, Emerging Challenges, and Strategic Insights
2025-2034 Nonmetallic Minerals Mining Support Activities Market Outlook: Key Dri …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Nonmetallic Minerals Mining Support Activities Industry Market Size Be by 2025? In the past few years, there has been a robust expansion in the size of the nonmetallic minerals mining support activities market. It is projected to escalate from $34.04 billion in 2024 to $36.55 billion
Professional Street Sweeper Industry Outlook 2025-2029: Market Set to Cross $3.18 Billion Milestone
Professional Street Sweeper Industry Outlook 2025-2029: Market Set to Cross $3.1 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Professional Street Sweeper Market Size By 2025? The market size of professional street sweepers has seen significant expansion in the past few years. The market, predicted to rise from $2.37 billion in 2024 to $2.5 billion in 2025, boasts a compound annual growth rate (CAGR)
Key Trends Reshaping the Industrial Wet Dust Collector Market: Advanced Filtration Technologies Empower Compliance With Environmental Standards Industry Transformation
Key Trends Reshaping the Industrial Wet Dust Collector Market: Advanced Filtrati …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Industrial Wet Dust Collector Market Size Growth Forecast: What to Expect by 2025? In recent times, there has been a robust growth in the size of the industrial wet dust collector market. It is expected to swell from $1.89 billion in 2024 to $2 billion by 2025, showing a

All 5 Releases


More Releases for RNA

CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes. CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic,
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032. This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through - • 70% efforts of Primary Research • 15% efforts of Secondary Research • 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate? • The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%. • Expected exponential
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032. The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may